Related Experiment Videos
Galectin-1 modulates human melanoma cell adhesion to laminin
F A van den Brûle1, C Buicu, M Baldet
1Metastasis Research Laboratory, University of Liège, Belgium.
Biochemical and Biophysical Research Communications
|April 17, 1995
Summary
Galectin-1 enhances melanoma cell adhesion to laminin, a key protein in basement membranes. This interaction may influence cancer cell invasion and metastasis, suggesting galectin-1 as a potential therapeutic target.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Galectins are a family of beta-galactoside-binding proteins with poorly defined functions.
- Galectin-1 specifically binds to poly-N-acetyllactosamine chains on laminin, a basement membrane glycoprotein.
- Melanoma cell interactions with the extracellular matrix are critical for metastasis.
Purpose of the Study:
- To investigate the role of galectin-1 in modulating the interaction between human melanoma cells and laminin.
- To determine if galectin-1 influences melanoma cell adhesion and spreading on laminin.
Main Methods:
- Detection of galectin-1 expression in human melanoma cell lines (A375, A2058).
- In vitro adhesion assays using recombinant galectin-1 and anti-galectin-1 antibodies.
- Assessment of melanoma cell spreading on laminin-coated surfaces.
Main Results:
- Human melanoma cells express galectin-1 intracellularly and on the cell surface.
- Recombinant galectin-1 dose-dependently increased melanoma cell attachment to laminin, an effect inhibited by lactose.
- Anti-galectin-1 antibodies dose-dependently inhibited melanoma cell adhesion to laminin.
- Neither galectin-1 nor its antibody affected melanoma cell spreading on laminin.
Conclusions:
- Galectin-1 plays a significant role in promoting melanoma cell adhesion to laminin.
- These findings suggest galectin-1 as a potential mediator of melanoma cell invasion and metastasis.
- Targeting galectin-1 could offer a novel strategy for inhibiting melanoma progression.